Key statistics
On Tuesday, Onkure Therapeutics Inc (OKUR:NMQ) closed at 17.29, 76.41% above the 52 week low of 9.80 set on Dec 14, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 17.50 |
---|---|
High | 17.50 |
Low | 16.89 |
Bid | 16.55 |
Offer | 18.50 |
Previous close | 17.55 |
Average volume | 67.22k |
---|---|
Shares outstanding | 13.34m |
Free float | 13.16m |
P/E (TTM) | -- |
Market cap | 230.64m USD |
EPS (TTM) | -12.25 USD |
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
- OnKure Announces Closing of Merger with Reneo Pharmaceuticals and Concurrent Private Placement of $65 Million
- Reneo Pharmaceuticals Announces Stockholder Approval of Merger with OnKure
- Reneo Pharmaceuticals Reports Second Quarter 2024 Financial Results
- Reneo Pharmaceuticals and OnKure Announce Proposed Merger
- Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
- Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
- Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
- Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results
More ▼